Status:
COMPLETED
Study of the Effect of Intramuscular Ephedrine on the Incidence of Nausea and Vomiting During Elective Cesarean Section
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
New York Presbyterian Hospital
Conditions:
Nausea
Vomiting
Eligibility:
FEMALE
18-40 years
Phase:
PHASE2
Brief Summary
The purpose of this research study is to investigate if the incidence of nausea and vomiting that subjects experience during and after a Cesarean section can be reduced by giving a shot of the drug ep...
Detailed Description
This research project is designed to study the medication ephedrine, when it is given as a routine part of the anesthesia for elective Cesarean section. Ephedrine is a medication that is widely used i...
Eligibility Criteria
Inclusion
- Must be pregnant with a single baby
- Must be at term in their pregnancy (estimated gestational age of at least 38 weeks)
- Must be scheduled for an elective Cesarean section
- Must be between 60-70" tall
- Must be free of severe systemic disease (ASA class I or II)
Exclusion
- Contraindication to spinal anesthesia
- Any allergy to any of the medications included in the study
- History of pregnancy-induced hypertension or preeclampsia
- History of preexisting hypertension
- Diabetes mellitus
- Hyperemesis gravidum
- Previous perioperative nausea and vomiting
- History of motion sickness
- Women carrying a fetus with a known abnormality will also be excluded from the study
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00432991
Start Date
February 1 2007
End Date
September 1 2010
Last Update
May 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York-Presbyterian Hospital; Weill Medical College of Cornell
New York, New York, United States, 10021